BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer

Anna Rita Alitto, Luca Tagliaferri, Valentina Lancellotta, Andrea D’Aviero, Antonio Piras, Vincenzo Frascino, Francesco Catucci, Bruno Fionda, Christian Staackmann, Simonetta Saldi, Vincenzo Valentini, Gyorgy Kovacs, Cynthia Aristei, Giovanna Mantini

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Background/Aim: The aim of the study was to evaluate acute and late genitourinary (GU) and gastrointestinal (GI) toxicity in patients with high- or intermediate-risk prostate cancer. Patients and Methods: We evaluated data of patients from three Radiation Oncology Departments (Rome, Lübeck and Perugia). Patients treated in Rome underwent exclusive intensity-modulated-radiotherapy (IMRT) or IMRT plus high-dose-rate interventional radiotherapy (HDR-IRT). IMRT plus two fractions HDR-IRT was performed in Lübeck, while in Perugia Helical Tomotherapy was performed. The Common Toxicity Criteria for Adverse Event (Version 4.03) scale was used to describe acute and late toxicity. Results: At a median follow-up of 28 months, all 51 patients were alive and disease-free. Patients treated by HDR-IRT plus VMAT showed only G1-2 genitourinary- gastrointestinal (GU-GI) acute and late toxicity. Univariate analysis showed a lower risk of acute GU toxicity (p=0.048) in IMRT+HDR-IRT. Conclusion: Low grade and less acute GU toxicity was observed in patients undergoing HDR-IRT boost.
Lingua originaleInglese
pagine (da-a)1297-1305
Numero di pagine9
RivistaIn Vivo
Volume34
DOI
Stato di pubblicazionePubblicato - 2020

Keywords

  • Aged
  • Aged, 80 and over
  • Brachytherapy
  • Disease Management
  • Dose Fractionation, Radiation
  • Focal therapy
  • HDR brachytherapy
  • Helical tomotherapy
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Personalized medicine
  • Prostate cancer
  • Prostatic Neoplasms
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Radiotherapy, Intensity-Modulated
  • Recurrence
  • Tomography, Spiral Computed
  • Toxicity
  • Treatment Outcome
  • VMAT

Fingerprint

Entra nei temi di ricerca di 'BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer'. Insieme formano una fingerprint unica.

Cita questo